<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">35523213</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>06</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1098-8785</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>06</Day>
            </PubDate>
          </JournalIssue>
          <Title>American journal of perinatology</Title>
          <ISOAbbreviation>Am J Perinatol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>First Trimester Cardiac Biomarkers among Women with Peripartum Cardiomyopathy: Are There Early Clues to This Late-Pregnancy Phenomenon?</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1055/s-0042-1748159</ELocationID>
        <Abstract>
          <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND"> Whether biomarkers may enable early identification of women who develop peripartum cardiomyopathy (PPCM) prior to disease onset remains a question of interest.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS"> A retrospective nested case-control study was conducted to determine whether first trimester <i>N</i>-terminal pro-B type natriuretic peptide (NT-proBNP) or high sensitivity cardiac troponin I (hs-cTnI) differed among women who developed PPCM versus unaffected pregnancies. Cases were matched to unaffected women by age, race, parity, and gestational age of sample (control A) and then further by blood pressure and pregnancy weight gain (control B).</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS"> First trimester NT-proBNP concentrations were numerically higher among women who subsequently developed PPCM (116 pg/mL [83-177]) as compared with women in control A (56.1 pg/mL [38.7-118.7], <i>p</i> = 0.3) or control B (37.6 [23.3 - 53.8], <i>p</i> &lt;0.05). A higher proportion of women who subsequently developed PPCM (50%) had detectable levels of hs-cTnI as compared with control A (0%, <i>p</i> = 0.03) or control B (18.8%, <i>p</i> = 0.52). Among both cases and controls, hs-cTnI values were low and often below the limit of detection.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS"> There were differences in first trimester NT-proBNP and hs-cTnI concentrations between women who subsequently developed PPCM and those who did not, raising the possibility the early pregnancy subclinical myocardial dysfunction may be associated with this late-pregnancy disease.</AbstractText>
          <AbstractText Label="KEY POINTS" NlmCategory="CONCLUSIONS">· 1st trimester NT-proBNP is numerically higher among women who subsequently develop PPCM.. · 1st trimester hs-cTnI was nominally higher among women who developed PPCM versus those who did not.. · A significant proportion of normal pregnant women have undetectable hs-cTnI..</AbstractText>
          <CopyrightInformation>Thieme. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Sarma</LastName>
            <ForeName>Amy A</ForeName>
            <Initials>AA</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Harvard Medical School, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hsu</LastName>
            <ForeName>Sarah</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Endocrinology, Diabetes Unit, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Januzzi</LastName>
            <ForeName>James L</ForeName>
            <Initials>JL</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Harvard Medical School, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Goldfarb</LastName>
            <ForeName>Ilona T</ForeName>
            <Initials>IT</Initials>
            <AffiliationInfo>
              <Affiliation>Harvard Medical School, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Thadhani</LastName>
            <ForeName>Ravi</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Harvard Medical School, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wood</LastName>
            <ForeName>Malissa J</ForeName>
            <Initials>MJ</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Harvard Medical School, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Powe</LastName>
            <ForeName>Camille E</ForeName>
            <Initials>CE</Initials>
            <AffiliationInfo>
              <Affiliation>Harvard Medical School, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of Endocrinology, Diabetes Unit, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Scott</LastName>
            <ForeName>Nandita S</ForeName>
            <Initials>NS</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Harvard Medical School, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>06</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Am J Perinatol</MedlineTA>
        <NlmUniqueID>8405212</NlmUniqueID>
        <ISSNLinking>0735-1631</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <CoiStatement>None declared.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>6</Day>
          <Hour>19</Hour>
          <Minute>2</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35523213</ArticleId>
        <ArticleId IdType="doi">10.1055/s-0042-1748159</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
